The treatment of skin immune diseases is one of the most successful cases in immunological translational medicine. Previously, the treatment of skin immune diseases was mainly achieved through accidental discovery of drugs or therapies, often with poor efficacy and certain toxicity during long-term treatment. With the application of biological agents, more and more patients are achieving the treatment goal of complete or almost complete clearance of skin lesions and itching. We still have many questions regarding the pharmaceutical mechanisms of biological agents, rational and safe use of drugs, long-term patient management, and early intervention.

In order to promote the development of skin immune diseases, psoriasis, urticaria and other fields, improve the level of precision diagnosis and treatment, use biological agents reasonably and safely, manage chronic diseases throughout the process, and reduce the disease burden on patients, the "Standardized Comprehensive Management Conference of Skin Chronic Diseases" hosted by Chengdu High tech Medical Association was held online on November 30, 2023. The conference invited Professor Lu Yonghong from Chengdu Second People's Hospital More than ten experts and scholars, including Professor Hu Qian from the First People's Hospital of Chengdu, Professor Li Yu from the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Professor Yan Xiaojun from the Fourth Hospital of West China of Sichuan University, and Professor Song Xiang from the People's Hospital of Sichuan Province, gave wonderful lectures on relevant topics. Representatives at the conference expressed great benefits and hoped to participate in similar conferences in the future.